According to a study published by Insure Insights, the global vulvodynia market is estimated to grow at a CAGR of 6.7% during the forecast period. Vulvodynia is the condition where there are intense pain and discomfort in the opening of the vulva, the cause of which is still unknown. This condition affects women and makes it difficult and painful for them to have intercourse, socialize, and exercise. Typically, there are two types of vulvodynia, generalized vulvodynia, and localized vulvodynia. Vulvodynia is caused by prolonged sitting, insertion of tampons, the wedding of tight undergarments, sexual intercourse, horseback riding, cycling, and extreme gynecologic examination. The rising number of women suffering from vulvodynia will result in a subsequent increase in the demand for the treatment of vulvodynia. This is estimated to drive the growth of the vulvodynia treatment market.

Top Driver: Growing Awareness About the Burden of Vulvodynia on the Healthcare Systems

Growing awareness about the burden of vulvodynia on the healthcare systems in developed economies is catalyzing the expansion of the vulvodynia treatment market. Also, growing awareness about the diagnostics for vulvodynia among clinicians, especially gynecologists, is fueling the growth of the global vulvodynia treatment market. Evolution in therapeutic interventions for managing vulvodynia is expected to create lucrative avenues in the market. The growing adoption of local anesthetics in the form of gel or cream to manage pain-related distress in the patient populations is a major factor boosting the vulvodynia treatment market. Increasing research activities on expanding first-line treatment for vulvodynia is also propelling market growth. In addition to this, the growing number of psychophysical studies is expected to fulfill unmet needs in the vulvodynia treatment market.

Anti-convulsant Segment is Estimated to Witness Significant Growth During the Forecast Period

The global wound care market has been segmented into local anesthetics, anticonvulsants, tricyclic antidepressants, and others based on the type of drugs. The anti-convulsant segment is estimated to grow at a significant rate during the forecast period. In vulvodynia treatment, anti-convulsant is the most preferred drug. Gabapentin is the most trusted anti-convulsant drug available in vulvodynia treatment. Based on the distribution channel, the market is categorized into hospital pharmacies, mail order pharmacies, and retail pharmacies.

  The Growing Government Investment and Favorable Reimbursement Policies to Benefit North America Market

The global vulvodynia market has been segmented into North America, Europe, Asia Pacific, and SAMEA. The rising concerns related to human health, the growing government investment and initiatives, and favorable reimbursement policies are the factors propelling the growth of the market in the North American region. Following North America, the European market is estimated to proliferate owing to the increasing research activities and the improved healthcare facilities. In the Asia Pacific region, steady market growth is being experienced due to the developing medical infrastructure both in the public and private sectors.

Players to Focus on Product Development

The global vulvodynia market is estimated to stay fragmented during the forecast period owing to the possible new entrants. The major players are adopting various strategies such as product launches, collaborations, mergers & acquisitions, and partnerships, which are contributing to the growth of the vulvodynia treatment market globally. collaborations. The major market players operating in the market include Pfizer Inc., Sanofi Aventis, Eli Lilly and Company, Depomed Inc., Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Upsher-Smith Laboratories, LLC, and others.

Scope of the Report

By Drug Type

• Local anesthetics
• Anticonvulsants
• Tricyclic antidepressants
• Others

By Distribution Channel    

• Hospital pharmacies
• Mail order pharmacies
• Retail pharmacies.

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.